- Home
- ANVS vs INTT Comparison
ANVS vs INTT Comparison
Compare ANVS & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | INTT |
|---|---|---|
| Founded | 2008 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 175.3M |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ANVS | INTT |
|---|---|---|
| Price | $2.54 | $14.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $13.50 | $13.50 |
| AVG Volume (30 Days) | ★ 382.0K | 145.8K |
| Earning Date | 03-16-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $66,801,000.00 |
| Revenue This Year | N/A | $13.07 |
| Revenue Next Year | N/A | $6.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 66.06 |
| 52 Week Low | $1.11 | $5.24 |
| 52 Week High | $5.50 | $15.01 |
Technical Indicators
Market Signals| Indicator | ANVS | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 71.87 |
| Support Level | $2.29 | $7.21 |
| Resistance Level | $2.63 | $15.01 |
| Average True Range (ATR) | 0.22 | 0.90 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 34.71 | 80.45 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About INTT inTest Corporation
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.